Weiss Multi-Strategy Advisers’s Sage Therapeutics SAGE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,602	Closed	-$293K	–	764
2021 Q3	$293K	Buy	6,602 +576	+10%	+$26.4K	0.01%	609
2021 Q2	$342K	Buy	6,026 +1,545	+34%	+$109K	0.01%	590
2021 Q1	$335K	Sell	4,481 -182	-4%	-$14.9K	0.01%	589
2020 Q4	$403K	Sell	4,663 -379	-8%	-$27.9K	0.01%	595
2020 Q3	$308K	Buy	5,042 +56	+1%	+$2.84K	0.01%	513
2020 Q2	$207K	Buy	+4,986	New	+$181K	0.01%	517
2015 Q2	–	Sell	-15,000	Closed	-$753K	–	518
2015 Q1	$753K	Buy	+15,000	New	+$645K	0.03%	340

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SAGE Position: Q4 2021 in Review

Weiss Multi-Strategy Advisers sold out of Sage Therapeutics (SAGE) in Q4 2021, closing a stake of 6,602 shares — an estimated $293K sold.

Weiss Multi-Strategy Advisers first reported a position in SAGE in Q1 2015 and held it in 7 quarters. The position peaked at $753K in Q1 2015. 217 funds tracked by Wall St. Rank hold SAGE as of Q4 2021.

Weiss Multi-Strategy Advisers reported no remaining Sage Therapeutics position as of Q4 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 6,602 Sage Therapeutics shares in Q4 2021, an estimated $293K.
Weiss Multi-Strategy Advisers first reported a position in Sage Therapeutics in Q1 2015 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Sage Therapeutics position peaked at $753K in Q1 2015.
217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.